Central Pharmaceuticals (DHA:CENTRALPHL) Total Liabilities : BDT597.52 Mil (As of Sep. 2022)

View and export this data going back to 2013. Start your Free Trial

What is Central Pharmaceuticals Total Liabilities?

Central Pharmaceuticals's Total Liabilities for the quarter that ended in Sep. 2022 was BDT597.52 Mil.

Central Pharmaceuticals's quarterly Total Liabilities declined from Mar. 2022 (BDT603.14 Mil) to Jun. 2022 (BDT597.67 Mil) and declined from Jun. 2022 (BDT597.67 Mil) to Sep. 2022 (BDT597.52 Mil).

Central Pharmaceuticals's annual Total Liabilities increased from Jun. 2021 (BDT582.62 Mil) to Jun. 2022 (BDT597.67 Mil) and increased from Jun. 2022 (BDT597.67 Mil) to Jun. 2023 (BDT597.96 Mil).

Central Pharmaceuticals Total Liabilities Historical Data

The historical data trend for Central Pharmaceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Central Pharmaceuticals Total Liabilities Chart

Central Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Liabilities

Get a 7-Day Free Trial

691.19

564.79

582.62

597.67

597.96

Central Pharmaceuticals Quarterly Data
	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Jun23
Total Liabilities	Get a 7-Day Free Trial															600.43	603.14	597.67	597.52	597.96

Central Pharmaceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Central Pharmaceuticals's Total Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	329.619	+	(231.978	+	36.358
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	597.96

Total Liabilities	=	Total Assets (A: Jun. 2023 )	-	Total Equity (A: Jun. 2023 )
	=	1267.831	-	669.877
	=	597.95

Central Pharmaceuticals's Total Liabilities for the quarter that ended in Sep. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	325.79	+	(231.978	+	39.748
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	597.52

Total Liabilities	=	Total Assets (Q: Sep. 2022 )	-	Total Equity (Q: Sep. 2022 )
	=	1302.267	-	704.751
	=	597.52

Central Pharmaceuticals Total Liabilities Related Terms

Thank you for viewing the detailed overview of Central Pharmaceuticals's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Central Pharmaceuticals (DHA:CENTRALPHL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Central Pharmaceuticals Ltd (DHA:CENTRALPHL) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

South West Darus Salam Road, 2-A/1, 2nd Floor, Mirpur - 1, Dhaka, BGD, 1216

Website

https://www.centralphl.com

Central Pharmaceuticals Ltd is engaged in the manufacturing and marketing of medicines in Bangladesh. The company manufactures finished formulation products for general people, hospitals, clinics, government organizations, corporations, and other non-government organizations. Its product portfolio encompasses therapeutic categories including gastrointestinal, anti-infective, vitamins and minerals, allergy cough and cold, analgesic and musculoskeletal, dermatological, oral rehydration salt, and others. The products are in the dosage forms of tablets, capsules, liquid, and ointments.

Central Pharmaceuticals (DHA:CENTRALPHL) Headlines

No Headlines